Toronto, Canada

Jonathan Balfour

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Inventure, LLC. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Balfour. Retrieved from https://idiyas.com/inventor/jonathan-balfour

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jonathan Balfour in Solvent-Free Gadolinium Contrast Agents

Introduction

Jonathan Balfour, an inventive mind based in Toronto, Canada, has made significant contributions to the field of medical imaging through his innovative work in developing solvent-free gadolinium contrast agents. With one patent to his name, Balfour is at the forefront of advancing safer and more efficient methods for medical applications.

Latest Patents

Jonathan Balfour’s notable patent involves complexes of gadolinium metal, ligands, and meglumine that are substantially free of non-aqueous solvents. The patent specifically discloses solvent-free complexes including gadopentetate dimeglumine and gadoterate meglumine, along with methods for their preparation. This innovation focuses on processes that purify reactants, monitor and control pH levels, quantify free gadolinium content, and measure the concentration of gadolinium-ligand complexes in aqueous solutions. Remarkably, the one-step process described in the patent eliminates the need to dry the highly hygroscopic gadolinium-ligand complex, incorporating purification steps that do not require non-aqueous solvents.

Career Highlights

Through his tenure at Inventure, LLC, Jonathan Balfour has exemplified a commitment to advancing medical imaging technology. His innovative solutions have not only streamlined processes but have also aimed to enhance patient safety and effectiveness in medical procedures.

Collaborations

Balfour's journey has also included collaborations with notable colleagues such as Richard Joseph Deslauriers and Michael Milbocker. Working within a dynamic team environment has allowed them to synergize their expertise, contributing to high-impact advancements in the realm of gadolinium contrast agents.

Conclusion

Jonathan Balfour's contributions through his patent on solvent-free gadolinium contrast agents mark a significant advancement in medical imaging technologies. His work represents the essence of innovation in the field, and with the support of collaborations at Inventure, LLC, Balfour is sure to continue making strides that benefit medical professionals and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…